Most read article(s)

Open Access
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Devon Stoliker, Gary F. Egan, Karl J. Friston and Adeel Razi
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews October 2022, 74 (4) 876-917; DOI: https://doi.org/10.1124/pharmrev.121.000508
Open Access
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio and Gabriella Gobbi
Michael Nader, ASSOCIATE EDITOR

Pharmacological Reviews January 2021, 73 (1) 202-277; DOI: https://doi.org/10.1124/pharmrev.120.000056
Open Access
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Maija Dambrova, Marina Makrecka-Kuka, Janis Kuka, Reinis Vilskersts, Didi Nordberg, Misty M. Attwood, Stefan Smesny, Zumrut Duygu Sen, An Chi Guo, Eponine Oler, Siyang Tian, Jiamin Zheng, David S. Wishart, Edgars Liepinsh and Helgi B. Schiöth
Jukka Hakkola, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 506-551; DOI: https://doi.org/10.1124/pharmrev.121.000408
You have access
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos, Ruin Moaddel, Patrick J. Morris, Lace M. Riggs, Jaclyn N. Highland, Polymnia Georgiou, Edna F. R. Pereira, Edson X. Albuquerque, Craig J. Thomas, Carlos A. Zarate and Todd D. Gould
Jeffrey M. Witkin, ASSOCIATE EDITOR

Pharmacological Reviews July 2018, 70 (3) 621-660; DOI: https://doi.org/10.1124/pr.117.015198
Open Access
Is Oxytocin “Nature’s Medicine”?
C. Sue Carter, William M. Kenkel, Evan L. MacLean, Steven R. Wilson, Allison M. Perkeybile, Jason R. Yee, Craig F. Ferris, Hossein P. Nazarloo, Stephen W. Porges, John M. Davis, Jessica J. Connelly and Marcy A. Kingsbury
Robert Dantzer, ASSOCIATE EDITOR

Pharmacological Reviews October 2020, 72 (4) 829-861; DOI: https://doi.org/10.1124/pr.120.019398
Open Access
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, Hiro Furukawa, Frank S. Menniti, Alexander I. Sobolevsky, Geoffrey T. Swanson, Sharon A. Swanger, Ingo H. Greger, Terunaga Nakagawa, Chris J. McBain, Vasanthi Jayaraman, Chian-Ming Low, Mark L. Dell’Acqua, Jeffrey S. Diamond, Chad R. Camp, Riley E. Perszyk, Hongjie Yuan and Stephen F. Traynelis
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews October 2021, 73 (4) 1469-1658; DOI: https://doi.org/10.1124/pharmrev.120.000131
You have access
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin, Stefano Comai and Gabriella Gobbi
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews April 2018, 70 (2) 197-245; DOI: https://doi.org/10.1124/pr.117.014381
Open Access
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner and Tom E. Mollnes
Finn Olav Levy, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 792-827; DOI: https://doi.org/10.1124/pharmrev.120.000072
Open Access
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya and Annamaria Vezzani
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2020, 72 (3) 606-638; DOI: https://doi.org/10.1124/pr.120.019539
Open Access
New Technologies Bloom Together for Bettering Cancer Drug Conjugates
Yiming Jin, Shahab Edalatian Zakeri, Raman Bahal and Andrew J. Wiemer
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 680-713; DOI: https://doi.org/10.1124/pharmrev.121.000499

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals